Clin2
NCT05424016Possibly a fitRecruiting

Propranolol for brain blood-vessel tumors in VHL

Hemangioblastoma of CNSVon Hippel-Lindau Disease

Treatments studied

Part of Brain & nervous system, Cancer, Genetic & congenital, Heart & circulation clinical trials.

This trial studies whether propranolol, a beta-blocker medicine, can help people with VHL who have non-urgent hemangioblastomas in the brain/spinal cord. It aims to see if the medication is safe and beneficial without needing immediate surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
85 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have VHL and at least one brain or spinal hemangioblastoma that does not need urgent surgery within 3 months
  • You can give written consent to join the study
  • You are covered by a social security plan
  • You are NOT already taking propranolol or another beta-blocker (like metoprolol)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07705529Not yet recruiting
Understanding VHL brain tumors in children

This study follows children with Von Hippel-Lindau disease to understand how hemangioblastomas in the brain and spine grow over time. It looks for patterns that might predict future problems, so doctors can plan better care.

Lille
NCT07167329Recruiting· Phase 2
Belzutifan for VHL syndrome: a real-world study

This trial tests the drug belzutifan (a pill taken by mouth) in people with VHL syndrome who have kidney or other VHL-related tumors that are growing or can be measured. The study looks at how well belzutifan works in real-world conditions and whether certain genetic factors affect how the drug works.

São Paulo, São Paulo
NCT06798363Recruiting· Phase 2/Phase 3
Testing different doses of propranolol for ulcerated hemangioma in children.

This trial tests different starting doses of oral propranolol to see which works best and is safest for treating infantile hemangiomas that have ulcers (sores). It may help your child heal faster.

Chengdu, Sichuan
NCT07528235Not yet recruiting· Phase 1
Propranolol to prevent complications after brain hemorrhage

This study tests whether a heart medication called propranolol, given intravenously (through an IV), can prevent serious infections in patients who have had bleeding in the brain. You would receive this treatment within 24 hours of your stroke symptoms starting.

Xi'an, Shaanxi
NCT06775080Recruiting· Phase 2
Testing propranolol before and after surgery for stomach or colon cancer

This trial tests if taking a medicine called propranolol around the time of surgery can improve outcomes for people with stomach or colon cancer that can be removed with an operation. Propranolol is a type of drug that blocks certain stress signals in the body and may help with recovery.

Shanghai, Shanghai Municipality
NCT06719804Not yet recruiting· Early Phase 1
Propranolol for drug-resistant focal epilepsy

This trial tests if adding propranolol (a beta-blocker usually used for high blood pressure) to your current epilepsy medicines can help control focal seizures that last a minute or longer and affect awareness. It's for people aged 18-60 whose seizures haven't been controlled by at least two other seizure medicines.

Hear when a new Von Hippel-Lindau Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.